4-Hydroxynonenal-modified amyloid-β peptide inhibits the proteasome: possible importance in Alzheimer’s disease*
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
The amyloid beta-peptide (Abeta) is a 4-kDa species derived from the amyloid precursor protein, which accumulates in the brains of patients with Alzheimer's disease. Although we lack full understanding of the etiology and pathogenesis of selective neuron death, considerable data do imply roles for both the toxic Abeta and increased oxidative stress. Another significant observation is the accumulation of abnormal, ubiquitin-conjugated proteins in affected neurons, suggesting dysfunction of the proteasome proteolytic system in these cells. Recent reports have indicated that Abeta can bind and inhibit the proteasome, the major cytoslic protease for degrading damaged and ubiquitin-conjugated proteins. Earlier results from our laboratory showed that moderately oxidized proteins are preferentially recognized and degraded by the proteasome; however, severely oxidized proteins cannot be easily degraded and, instead, inhibit the proteasome. We hypothesized that oxidatively modified Abeta might have a stronger (or weaker) inhibitory effect on the proteasome than does native Abeta. We therefore also investigated the proteasome inhibitory action of Abeta1-40 (a peptide comprising the first 40 residues of Abeta) modified by the intracellular oxidant hydrogen peroxide, and by the lipid peroxidation product 4-hydroxynonenal (HNE). H2O2 modification of Abeta1-40 generates a progressively poorer inhibitor of the purified human 20S proteasome. In contrast, HNE modification of Abeta1-40 generates a progressively more selective and efficient inhibitor of the degradation of fluorogenic peptides and oxidized protein substrates by human 20S proteasome. This interaction may contribute to certain pathological manifestations of Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Effects of oxidative modification on the proteolytic susceptibility of hemoglobin. [ 3 H]-hemoglobin was exposed to various concentrations of hydrogen peroxide, microconcentrated, and then incubated for 1 h at 37 °C with purified human proteasome, to measure proteolytic susceptibility. All data are the means and SEs of three experiments.](https://figures.cochat.ai/paper-figures/fb1a617b5fd8485eb2889ac8c7402135/4-hydroxynonenal-modified-amyloid-peptide-inhibits-the-proteasome-possible-figure-2.png)
![Figure 3 Effects of A b 1-40 on the degradation of native and oxidized hemoglobin by the proteasome. A b 1-40 was oxidized as described in Materials and methods. Purified proteasome was incubated with various concentrations of oxidized A b 1-40 for 1 h at room temperature. Next, native [ 3 H]-Hb or [ 3 H]-Hb oxidized with H2O2 was added, and proteolysis was allowed to proceed for 1 h at 37 °C. Percent hemoglobin degradation was calculated as described in Materials and methods. Data are represented as means 9 SEs of triplicate samples from a total of four experiments. ( A ) Percent degradation of both native and oxidized (20 mM H2O2) [ 3 H]-hemoglobin by the purified human 20S proteasome, in the presence of native A b 1-40 . ( B ) Effect of oxidized A b 1-40 (30 mM H2O2) on the degradation of both native and oxidized (20 mM H2O2) hemoglobin by the proteasome.](https://figures.cochat.ai/paper-figures/1fdebe28f4e6449ea8bed334bd2748d9/4-hydroxynonenal-modified-amyloid-peptide-inhibits-the-proteasome-possible-figure-3.png)

![Figure 4 Oxidation of A b 1-40 inactivates its ability to inhibit the proteasome. Shown is the progressive oxidation of A b 1-40 as measured by carbonyl production with exposure to increasing concentrations of H2O2 ( A ) and that increasing oxidation progressively inactivates the ability of A b 1-40 to inhibit degradation of both native and oxidized hemoglobin by the proteasome ( B ). Carbonyl measurements, exposure of A b 1-40 and hemoglobin to H2O2, and calculation of percent hemoglobin degradation were performed as described in Materials and methods. Data are represented as means and SEs from four experiments. ( A , B ) The extent of A b oxidation was varied by pre-exposure to 0-30 mM hydrogen peroxide. ( B ) Purified human 20S proteasome was incubated with progressively oxidized A b for 1 h at room temperature. Next, native [ 3 H]-Hb or [ 3 H]-Hb oxidized with 20 mM H2O2 was added and proteolysis was allowed to proceed for 1 h at 37 °C.](https://figures.cochat.ai/paper-figures/e7b16cbaaa504574bcf9d609b4cbc07c/4-hydroxynonenal-modified-amyloid-peptide-inhibits-the-proteasome-possible-figure-4.png)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Proteasome dysfunction has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer’s disease [14], Parkinson’s disease [15], Huntington’s disease [16], and amyotrophic lateral sclerosis [17].”
From PSMC5 insufficiency and P320R mutation impair proteasome function (2024) · cites this paper as [14]
In the citing paper
“4-HNE-modified amyloid β peptides have been found to inhibit proteasomal function, leading to neuroinflammation which exacerbates neurodegeneration [51,53].”
From Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease? (2022) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[49] Determination of carbonyl content in oxidatively modified proteins
Levine, R. L., Garland, D., Oliver, C. N., Amici, A., Climent, I., Lenz, A.-G., Ahn, B.-W., Shaltiel, S., & Stadtman, E. R. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86141-h · Cited by 5,887
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Protein Oxidation in Aging, Disease, and Oxidative Stress
Berlett, B. S., & Stadtman, E. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20313 · Cited by 3,332
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,487
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
The ubiquitin-proteasome proteolytic pathway
Ciechanover, A. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,791
Goldgaber, D., Lerman, M. I., McBride, O. W., Saffiotti, U., & Gajdusek, D. C. (1987) · Science · doi:10.1126/science.3810169 · Cited by 1,333
The Genetic Defect Causing Familial Alzheimer's Disease Maps on Chromosome 21
St George-Hyslop, P. H., Tanzi, R. E., Polinsky, R. J., Haines, J. L., Nee, L., Watkins, P. C., Myers, R. H., Feldman, R. G., Pollen, D., Drachman, D., et al. (1987) · Science · doi:10.1126/science.2880399 · Cited by 1,163
Ubiquitin Is a Component of Paired Helical Filaments in Alzheimer's Disease
Mori, H., Kondo, J., & Ihara, Y. (1987) · Science · doi:10.1126/science.3029875 · Cited by 843
Radioactive Labeling of Proteins in Vitro
Rice, R. H., & Means, G. E. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62484-6 · Cited by 835
Cited by
Items 101–141 of 141
Extracellular Vesicles and Cancer Therapy: Insights into the Role of Oxidative Stress
Ho, J., Chaiswing, L., & Clair, D. K. S. (2022) · Antioxidants · doi:10.3390/antiox11061194 · Cited by 27
Homma, T., Kurahashi, T., Lee, J., Kang, E. S., & Fujii, J. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.07.023 · Cited by 24
Sultana, R., & Butterfield, D. A. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780024 · Cited by 24
Santos, S. D., Cardoso, I., Magalhães, J., & Saraiva, M. J. (2007) · The Journal of Pathology · doi:10.1002/path.2224 · Cited by 25
Hosler, M. R., Wang-Su, S.-T., & Wagner, B. J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00397-7 · Cited by 21
Increased protein hydrophobicity in response to aging and Alzheimer disease
Dasuri, K., Ebenezer, P. J., Zhang, L., Fernandez‐Kim, S. O., Bruce‐Keller, A. J., Markesbery, W. R., & Keller, J. N. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.02.012 · Cited by 20
Ding, Q., & Keller, J. N. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5307 · Cited by 23
Electrophilic Cyclopentenone Isoprostanes in Neurodegeneration
Musiek, E. S., McLaughlin, B., & Morrow, J. D. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0042-3 · Cited by 20
Anastasio, T. J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00085 · Cited by 18
Amyloid-β Peptide-Induced Secretion of Endoplasmic Reticulum Chaperone Glycoprotein GRP94
Viana, R. J. S., Steer, C. J., & Rodrigues, C. M. P. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-100395 · Cited by 17
Sang, C., Kobayashi, Y., Du, J., Katsumo, M., Adachi, H., Doyu, M., & Sobue, G. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00460-6 · Cited by 16
Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease?
Hindle, A., Singh, S. P., Pradeepkiran, J. A., Bose, C., Vijayan, M., Kshirsagar, S., Sawant, N. A., & Reddy, P. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116098 · Cited by 14
“4-HNE-modified amyloid β peptides have been found to inhibit proteasomal function, leading to neuroinflammation which exacerbates neurodegeneration [51,53].”
BackgroundProteasome and Neurodegeneratıve Diseases
Catalgol, B., & Grune, T. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397863-9.00011-0 · Cited by 15
Self-citationProteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer’s Disease
Sulistio, Y. A., & Heese, K. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/393510 · Cited by 11
Changes in brain proteasome dynamics associated with aging
Nago, N., Murata, S., Tanaka, K., & Tanahashi, N. (2024) · Genes to Cells · doi:10.1111/gtc.13113 · Cited by 9
SDR enzymes oxidize specific lipidic alkynylcarbinols into cytotoxic protein-reactive species
Demange, P., Joly, E., Marcoux, J., Zanon, P. R. A., Listunov, D., Rullière, P., Barthes, C., Noirot, C., Izquierdo, J.-B., Rozié, A., et al. (2022) · eLife · doi:10.7554/elife.73913 · Cited by 9
Oxidative Stress and Protein Oxidation
Grune, T., Catalgol, B., & Jung, T. (2012) · Wiley eBooks · doi:10.1002/9781118493038.ch1 · Cited by 8
Long, M. J. C., Huang, K., & Aye, Y. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00467k · Cited by 7
In Vitro Aging of Human Skin Fibroblasts: Age-Dependent Changes in 4-Hydroxynonenal Metabolism
Petković, I., Bresgen, N., Gilardoni, E., Regazzoni, L., Uchida, K., Aldini, G., Siems, W., & Eckl, P. (2020) · Antioxidants · doi:10.3390/antiox9020150 · Cited by 7
Effects of Gsta4 deficiency on age-related cochlear pathology and hearing loss in mice
Park, H., Kim, M., Han, C. J., White, K., Ding, D., Boyd, K., Salvi, R., & Someya, S. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110872 · Cited by 7
Smyth, S. P., Nixon, B., Skerrett-Byrne, D. A., Burke, N. D., & Bromfield, E. G. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0314 · Cited by 6
Oxidized proteins & ubiquitin conjugates
Gracy, R. W. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00347-5 · Cited by 6
PSMC5 insufficiency and P320R mutation impair proteasome function
Yu, Z.-Q., Carmichael, J., Collins, G. A., D'Agostino, M. D., Lessard, M., Firth, H. V., Harijan, P., Fry, A. E., Dean, J., Zhang, J., et al. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae085 · Cited by 4
“Proteasome dysfunction has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer’s disease [14], Parkinson’s disease [15], Huntington’s disease [16], and amyotrophic lateral sclerosis [17].”
Highbrow proteasome in high-throughput technology
Gaczynska, M. E., Rodriguez, K. A., Madabhushi, S., & Osmulski, P. A. (2006) · Expert Review of Proteomics · doi:10.1586/14789450.3.1.115 · Cited by 3
Davidson, K., Bano, M., Parker, D. J., Rodriguez, K., Osmulski, P. A., Gaczynska, M. E., & Pickering, A. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.23.619877 · Cited by 3
Protein Oxidation in Some Age‐Related Diseases
Grune, T., Karademir-Yilmaz, B., & Jung, T. (2012) · Wiley eBooks · doi:10.1002/9781118493038.ch4 · Cited by 2
Self-citationKavianinia, I., Yang, S., Kaur, H., Harris, P. W. R., Dobson, R. C. J., Fairbanks, A. J., & Brimble, M. A. (2017) · Chemical Communications · doi:10.1039/c7cc05025a · Cited by 2
Sha, W. (2006) · VTechWorks (Virginia Tech) · Cited by 2
Ubiquitin Conjugates: A Sensitive Marker of Oxidative Stress
Shang, F., & Taylor, A. (2010) · Wiley eBooks · doi:10.1002/9780813814438.ch13 · Cited by 2
Grune, T., Karademir-Yilmaz, B., & Jung, T. (2012) · Wiley eBooks · doi:10.1002/9781118493038.ch2 · Cited by 1
Self-citationDaroff, R. B., & Griggs, R. C. (2006) · Neurology · doi:10.1212/01.wnl.0000254935.78866.b9 · Cited by 1
RetractedMutant ubiquitin and the proteasome in Alzheimer's disease
de Vrij, F. M. S. (2005) · UvA-DARE (University of Amsterdam)
Role of Oxidatively Stressed Lipids in Amyloid Formation and Toxicity
Axelsen, P. H., & Komatsu, H. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch27
The Proteasome: Source and a Target of Oxidative Stress?
Halliwell, B. B. (2007) · Springer eBooks · doi:10.1007/0-387-28500-8_6
Roe, M. R. (2010) · University of Minnesota Digital Conservancy (University of Minnesota)
Sultana, R., & Butterfield, D. A. (2007) · Wiley eBooks · doi:10.1002/9783527622153.ch23
Proteomics Analysis in Alzheimer's Disease: New Insights into Mechanisms of Neurodegeneration
Butterfield, D. A., & Sultana, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_13
Viana, R. J. S. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Derivations of Tissue Slice Technology as Toxicological Screening Systems
Catania, J. M. (2006) · UA Campus Repository (The University of Arizona)
Links between Aging and Proteostasis Decline in Saccharomyces cerevisiae
Andersson, V. (2014) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Metadata
- Authors
- Shringarpure, R., Grune, T., Sitte, N., & Davies*, K. J. A.
- Affiliations
- University of Southern California (US)
- Humboldt-Universität zu Berlin (DE)
- Venue
- Cellular and Molecular Life Sciences
- Published
- 2000-10
- Volume
- 57
- Issue
- 12
- Pages
- 1802-1809
- ISSN
- 1420-682X (ISSN-L)
- PMC
- PMC11149552
- OpenAlex
- W2097355576
- Cited by
- 140
- References
- 35
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 6 · 2016: 7 · 2015: 3 · 2014: 5 · 2013: 4 · 2012: 9
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cellular and Molecular Life Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Environmental Health Sciences (ES03598)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- amyloid-beta, 4-hydroxynonenal, proteasome inhibition, Alzheimer's disease, oxidative stress, hydrogen peroxide, lipid peroxidation, 20S proteasome, protein oxidation, Aβ40, fluorogenic peptide substrates
- MeSH terms
- Aldehydes, Alzheimer Disease, Cysteine Endopeptidases, Erythrocytes, Hemoglobins, Humans, Hydrogen Peroxide, Multienzyme Complexes, Oxidation-Reduction, Oxyhemoglobins, Peptide Fragments, Protease Inhibitors, Lipid Peroxidation, Amyloid beta-Peptides, Proteasome Endopeptidase Complex, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.